References
- Beaumont J. L. Nouvelle méthods de dosage de l'héparine dans le sang- et les humeurs. Sang 1953; 24: 418
- Blombäck B., Blombäck M., Senning A., Wal-Len P. Om bestämning av blodets heparin-halt vid kirurgiska inngrepp. Svenska läkar-tidn 1955; 52: 561
- Brambel C. E., Corvin A. H., Oapone V. A. Mechanism of action of heparin as an etiological basis for homeostasis (hemorrhage and thrombisis). Am. J. Med. Sc 1955; 230: 276
- Burstein M. Substances fibrinoplastiques et anti-fibrinoplastiques. Rev. d'hémat 1952; 7: 587
- Burstein M. Sur l'effet antagonistc de l'héparine au cours de la deuxième phase de la coagulation. Se-maine d'hôp. Paris 1954; 30: 1
- Burstein M. Guinand, A.: Sur Taction antithrombinique de l'héparine. Role du fibrinogène et de la concentration en héparine. Rev. d'hémat 1953a; 8: 156
- Burstein M. Recherches sur Taction anticoagulatnte de l'héparine. Rôle du pH. Effet favorisante du citrate trisodique. Rev. d'hémat 1953b; 8: 44
- Burstein M. Sur le temps de thrombine du plasma héparina. Action des substances fibrinoplastiques. Rev. d'hémat 1955; 10: 527
- Chargaff E., Olson K. B. Studies on the chemistry of blood coagulation. VI. Studies on the action of heparin and other anticoagulants. The influence of protamine on the anticoagulant effect in vivo. J. Biol. Chem 1937-38; 122: 153
- Conley C., Hartmann C. R., Lalley J. S. The relationship of heparin activity to platelet concentration. Proc. Soc. Exper. Biol. & Med 1948; 69: 284
- Conley C., Hartmann C. R., Morse W. I. The clotting behaviour of human “platelet free” plasma. Evidence for the existence of a “plasma thromboplastin”. J. Clin. Investigation 1949; 28: 340
- Fischer A. Die Bindung von Heparin and Ei-weiss. Biochem Ztschr 1935; 273: 133
- Fitzgerald M. A., Waugh D. F. Characterization of a heparin cofactor obtained from bovine plasma fraction I. Arch. Biochem 1955; 58: 431
- Godal H. C. Interaction of protamine with human fibrinogen, and the significance of this interaction for the coagulation of fibrinogen with thrombin. Scandinav. J. Clin. & Lab. Investigation 1960a, In press
- Godal H. C. A comparison between two heparin-neutralizing agents: protamine and polybrene. Ibid 1960b, In press
- Gormsen J. Koagulationsproblemer ved acut coronartromibose. Thesis, Copenhagen 1957
- Hjort P., Stormorken H. A study of the in vitro and in vivo effect of a synthetic heparin-like anticoagulant: Dextran sulphate. Scandinav. J. Clin. & Lab. Investigation 1957; 9: Suppl. 29
- Jacques L. B., Mustard R. A. Some factors influencing the anticoagulant action of heparin. Biochem. J 1940; 34: 153
- Mellanby J. Heparin and blood coagulation. Proc. Roy. Soc. Med 1934-35; 116: 1
- Nilssou I. M., Wenckert A. Demonstration of a heparin-like anticoagulant in normal blood. Acta med. Scandinav 1954; 150: Suppl. 297
- Preston F. W., Parker R. P. New antiheparin agent “Polybrene”. Effect in peptone shock and experimental radiation. A.M.A. Arch. Surg 1953; 66: 545
- Quick A. J. On the action of heparin and its relation to thromboplastin. Am. J. Physiol 1936; 115: 317
- Quick A. J. The normal aatithrombin of the blood, and its relation to heparin. Ibid 1938; 123: 712
- Refn I., Vestergaard L. The titration of heparin with protamine. Scandinav. J. Clin. & Lab. Investigation 1954; 6: 284
- Stormorken H. Reactivity of stored plasma to thrombin, with reference to the fibrinogen conversion accelerator and heparinoid activity. Brit. J. Haemat 1957; S: 299
- Triataphyllopoulos D. C. Blood globulins reducing the anticoagulant activity of heparin. Canad. J. Biochem 1956; 34: 939
- Triataphyllopoulos D. C. Quick, A. J. & Greenwalt, T. J.: Action of disodium ethylenediamine tetracetate on blood coagulation. Evidence of the development of heparinoid activity during incubation or aeration of plasma. Blood 1955; 10: 534